Saturday, December 5, 2020

Amwell files for IPO, strikes partnership with Google

Boston-based telehealth company Amwell plans to go public, including a $100 million investment from Google.  The company filed preliminary paperwork with the Securities and Exchange Commission to be listed on the New York Stock Exchange under the symbol AMWL. Amwell plans to raise $100 million in the offering — likely a placeholder number, as...

FDA’s emergency authorization for convalescent plasma in Covid-19 sparks controversy

A decision by the Food and Drug Administration to grant an emergency use authorization for antibody-rich plasma taken from recovered Covid-19 patients for treating those hospitalized with the disease has come under criticism from some experts. Despite the lack of data from large, randomized controlled trials of convalescent plasma, the EUA that the FDA...

Riding the digital wave through COVID-19

As the first wave of infections arrived, we saw near-instant digital innovation that might otherwise have taken years: the rapid roll-out of remote working platforms, shared care record projects, electronic patient record configurations, and virtual clinics and consultations. NHS Digital increased the capacity and range of NHS 111 (the 24/7 telephone and online...

Kronos Bio raises $155M in private financing to advance lead leukemia drug into registration study next year

venture capital,money,business,Investor
A startup planning to enter a blood cancer drug into late-stage clinical development next year has raised more than $150 million in a private financing. San Mateo, California-based Kronos Bio said Monday that it had raised the $155 million financing of convertible notes, with $148 million raised to date and the remaining $ 7...

Nearly one-third of parents plan to keep kids home for school, according to JAMA survey

Staff members at Woodlin Elementary School distribute computers to parents of Montgomery County students who do not have them March 26, 2020 in Silver Spring, Maryland. Photo credit: Win McNamee, Getty Images Nearly one third of parents plan to keep their kids at home this fall, according to a survey published in JAMA Pediatrics....

The e-doctor will see you now

The term ‘doctor in a box’ – once used as a derisive term for physicians that provide primary health care at an hourly rate in unaffiliated ambulatory care clinics – has taken on a very different meaning. There, for the past seven years, it has been used to describe several formats of telemedicine...

Pfizer, Germany’s BioNTech release new data on Covid-19 vaccine

Early clinical trial data from a Covid-19 vaccine that is among those currently in late-stage testing have shown favorable responses among participants in terms of antibody and immune cell responses. Mainz, Germany-based BioNTech and New York-based Pfizer said late Thursday afternoon that among U.S. Phase I study participants receiving the vaccine BNT162b2 at 30...

Founders’ story: Pleiogenix – MedCity News

Pleiogenix is a biopharma startup developing treatments for liver diseases as well as Covid-19 and  non-alcoholic steatohepatitis (NASH), which recently took part in the INVEST Pitch Perfect contest and emerged victorious in the biopharma track. In this Q&A, CEO and Co-founder Joseph Evans talks about the company’s approach. Joseph Evans, Pleiogenix CEO Why did...

Purdue Pharma accused of causing $2.2T in damages amid opioid epidemic

The maker of a painkiller seen as one of the chief culprits in the opioid crisis is being accused of causing more than $2 trillion in damages. Nearly all the states, plus the District of Columbia and territories, made claims against Purdue Pharma totaling $2.156 trillion in connection with the bankruptcy filing the company...

Regeneron, Roche team up in global deal on Covid-19 antibody cocktail

A major European pharmaceutical company has signed on to distribute an antibody drug under development for Covid-19 outside the U.S. Tarrytown, New York-based Regeneron Pharmaceuticals said Wednesday that it had made an agreement with Swiss drugmaker Roche to partner and the development and manufacture of REGN-COV2, Regeneron’s monoclonal antibody treatment for SARS-CoV-2 infection. Under...
0FansLike
0FollowersFollow
- Advertisement -

Must Read